Business & Finance
Nordic Nanovector ASA incurs higher comprehensive loss of NOK336.8m in fiscal 2018
27 February 2019 -

Cancer care company Nordic Nanovector ASA (OSE:NANO) stated on Tuesday that it recorded a comprehensive loss of NOK336.8m for the full year 2018.

This is a decline when compared with comprehensive loss of NOK295.6m in 2017.

Revenues of NOK0.0m were generated for the full year 2018, down against revenues of NOK0.3m in 2017.

Total operating expenses of NOK340.0m were recorded for the full year 2018, over total operating expenses of NOK316.8m in 2017.

Cash and cash equivalents was NOK440.1m at the end of December 2018, a fall from cash and cash equivalents of NOK756.6m in 2017.